title: Opioid-Induced Constipation Part 2: Newer Therapies #295.
authors.forename: Andrew
authors.initials: A
authors.lastname: Badke
authors.forename: Drew A
authors.initials: DA
authors.lastname: Rosielle
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D003248:Constipation / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D009019:Morphinans / Q000627:therapeutic use; D009270:Naloxone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009271:Naltrexone / Q000031:analogs & derivatives / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use
chemical_list: D000701:Analgesics, Opioid; D009019:Morphinans; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009270:Naloxone; D011092:Polyethylene Glycols; C000589308:naloxegol; D009271:Naltrexone; C024224:naloxazone